Literature DB >> 10082341

Organ growth in Rett syndrome: a postmortem examination analysis.

D D Armstrong1, J K Dunn, R J Schultz, D A Herbert, D G Glaze, K J Motil.   

Abstract

Rett syndrome is a disorder of unknown etiology in females that manifests as severe mental and motor retardation during the first years of life. A postnatal pattern of altered growth is its earliest clinical expression. Head growth decelerates during the first year of age and is followed by a decline in somatic (height/weight) growth. The decreased occipitofrontal circumference (OFC) is reflected in decreased brain size, and measurements of the dendrites of cortical neurons suggest that a developmental and growth arrest have occurred. To further document growth in Rett syndrome, measurements of organ weights, as recorded in 39 postmortem examination studies were compared with normal organ weights for females of comparable age and height. These organ weights suggest that the pattern of growth failure in Rett syndrome, as compared with other forms of mental handicap, such as Down syndrome and Turner's syndrome, may be unique. In Rett syndrome the rate of brain growth, as derived from OFC, decelerates after birth. The increment in normal brain weight after 4 years of age, the age of the first postmortem examinations, is not observed in the Rett brain. The heart, kidneys, liver, and spleen grow at the normally defined rate until 8-12 years of age, when their growth rate decelerates, but their growth continues achieving organ weights that are appropriate for the height of the female. Adrenal weights are normal. These observations suggest that despite a generalized decreased growth in Rett syndrome the brain may be preferentially affected in this syndrome.

Entities:  

Mesh:

Year:  1999        PMID: 10082341     DOI: 10.1016/s0887-8994(98)00124-6

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  10 in total

1.  DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals.

Authors:  G Fan; C Beard; R Z Chen; G Csankovszki; Y Sun; M Siniaia; D Biniszkiewicz; B Bates; P P Lee; R Kuhn; A Trumpp; C Poon; C B Wilson; R Jaenisch
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

Review 2.  Rett syndrome and MeCP2: linking epigenetics and neuronal function.

Authors:  Mona D Shahbazian; Huda Y Zoghbi
Journal:  Am J Hum Genet       Date:  2002-11-19       Impact factor: 11.025

Review 3.  Cardiac disease and Rett syndrome.

Authors:  M Acampa; F Guideri
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

4.  Ocular MECP2 protein expression in patients with and without Rett syndrome.

Authors:  Deepali Jain; Kamaljeet Singh; Sankar Chirumamilla; Genila M Bibat; Mary E Blue; Sakkubai R Naidu; Charles G Eberhart
Journal:  Pediatr Neurol       Date:  2010-07       Impact factor: 3.372

Review 5.  The molecular pathology of Rett syndrome: synopsis and update.

Authors:  Schahram Akbarian; Yan Jiang; Genevieve Laforet
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

6.  Vitamin D modulates cortical transcriptome and behavioral phenotypes in an Mecp2 heterozygous Rett syndrome mouse model.

Authors:  Mayara C Ribeiro; Jessica L MacDonald
Journal:  Neurobiol Dis       Date:  2022-01-25       Impact factor: 5.996

7.  Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations.

Authors:  Jennifer L Larimore; Christopher A Chapleau; Shinichi Kudo; Anne Theibert; Alan K Percy; Lucas Pozzo-Miller
Journal:  Neurobiol Dis       Date:  2009-01-03       Impact factor: 5.996

8.  Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling.

Authors:  Claudia Fuchs; Stefania Trazzi; Roberta Torricella; Rocchina Viggiano; Marianna De Franceschi; Elena Amendola; Cornelius Gross; Laura Calzà; Renata Bartesaghi; Elisabetta Ciani
Journal:  Neurobiol Dis       Date:  2014-06-18       Impact factor: 5.996

9.  Mapping pathological phenotypes in a mouse model of CDKL5 disorder.

Authors:  Elena Amendola; Yang Zhan; Camilla Mattucci; Enrico Castroflorio; Eleonora Calcagno; Claudia Fuchs; Giuseppina Lonetti; Davide Silingardi; Alexei L Vyssotski; Dominika Farley; Elisabetta Ciani; Tommaso Pizzorusso; Maurizio Giustetto; Cornelius T Gross
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

10.  MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background.

Authors:  Clementina Cobolli Gigli; Linda Scaramuzza; Anna Gandaglia; Elisa Bellini; Marina Gabaglio; Daniela Parolaro; Charlotte Kilstrup-Nielsen; Nicoletta Landsberger; Francesco Bedogni
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.